Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies ; volume:15 ; number:1 ; day:30 ; month:3 ; year:2024 ; pages:1-19 ; date:12.2024
Nature Communications ; 15, Heft 1 (30.3.2024), 1-19, 12.2024
- Urheber
-
Daneshmandi, Saeed
Choi, Jee Eun
Yan, Qi
MacDonald, Cameron R.
Pandey, Manu
Goruganthu, Mounika
Roberts, Nathan
Singh, Prashant K.
Higashi, Richard M.
Lane, Andrew N.
Fan, Teresa W-M
Wang, Jianmin
McCarthy, Philip L.
Repasky, Elizabeth A.
Mohammadpour, Hemn
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-47096-9
- URN
-
urn:nbn:de:101:1-2406171033450.496854365406
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Daneshmandi, Saeed
- Choi, Jee Eun
- Yan, Qi
- MacDonald, Cameron R.
- Pandey, Manu
- Goruganthu, Mounika
- Roberts, Nathan
- Singh, Prashant K.
- Higashi, Richard M.
- Lane, Andrew N.
- Fan, Teresa W-M
- Wang, Jianmin
- McCarthy, Philip L.
- Repasky, Elizabeth A.
- Mohammadpour, Hemn
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hematologic malignancies
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Genomic testing for germline predisposition to hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Immunotherapy in hematologic malignancies: past, present, and future
CAR-T cell combination therapies in hematologic malignancies
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Hematologic malignancies
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Genomic testing for germline predisposition to hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Immunotherapy in hematologic malignancies: past, present, and future
CAR-T cell combination therapies in hematologic malignancies
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Hematologic malignancies
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Genomic testing for germline predisposition to hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Immunotherapy in hematologic malignancies: past, present, and future
CAR-T cell combination therapies in hematologic malignancies